BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/28/2023 2:11:45 PM | Browse: 367 | Download: 1088
 |
Received |
|
2022-11-20 11:31 |
|
Peer-Review Started |
|
2022-11-20 11:32 |
|
First Decision by Editorial Office Director |
|
2023-01-02 21:29 |
|
Return for Revision |
|
2023-01-02 21:29 |
|
Revised |
|
2023-01-12 18:18 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-03-06 03:32 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-03-14 18:41 |
|
Articles in Press |
|
2023-03-14 18:41 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-20 11:56 |
|
Publish the Manuscript Online |
|
2023-03-28 12:59 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Autoimmune liver diseases and SARS-CoV-2
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Costantino Sgamato, Alba Rocco, Debora Compare, Stefano Minieri, Stefano Andrea Marchitto, Simone Maurea and Gerardo Nardone |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alba Rocco, PhD, Doctor, Doctor, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via S. Pansini, 5, Naples 80131, Italy. a.rocco@unina.it |
| Key Words |
Autoimmune liver disease; SARS-CoV-2; COVID-19; COVID-19 vaccine; Autoimmune hepatitis |
| Core Tip |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a possible trigger of autoimmunity. Patients with autoimmune liver diseases (AILDs) were considered at higher risk of SARS-CoV-2 infection and more susceptible to severe coronavirus disease 2019 (COVID-19) due to genetic background and immunosuppressive treatments. Case reports documenting autoimmune hepatitis-like syndromes after the COVID vaccine started to emerge, raising worries about a possible risk of unwanted immunological side effects, especially in individuals predisposed to autoimmune disorders. We herein discuss the consequences of SARS-CoV-2 infection in patients with AILDs and the role of the vaccines in inducing liver autoimmunity. |
| Publish Date |
2023-03-28 12:59 |
| Citation |
Sgamato C, Rocco A, Compare D, Minieri S, Marchitto SA, Maurea S, Nardone G. Autoimmune liver diseases and SARS-CoV-2. World J Gastroenterol 2023; 29(12): 1838-1851 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i12/1838.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i12.1838 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
